Injectable Drug Delivery Market Briefing on Growing at a CAGR of 8.3% From 2021 to 2026, Finds Coherent Market Insights

Injectable Drug Delivery Market to Surpass US$ 32.5 Billion By 2026

Global Injectable Drug Delivery Market, accounted for US$ 15,939.0million in 2021 and is expected to witness a CAGR of 8.3% over the forecast period (2018 – 2026), as highlighted in a new report published by CMI.

Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/2768

Rising launch and approval of products by players in the market to increase the growth of the global injectable drug delivery market. Major players in the global injectable drug delivery market are laying emphasis on the development and approval of products by regulatory authorities, for catering to the demands of patients suffering from chronic diseases. For instance, Genentech, in October 2018, announced the approval of the U.S. Food and Drug Administration (FDA) for single-dose prefilled syringes (PFS), Xolair (omalizumab) as an added formulation for treating both chronic idiopathic urticaria (CIU) and allergic asthma indications. Similarly, European Commission, in August 2018, approved AstraZeneca's latest autoinjector pen for diabetes - Bydureon Bcise, thereby providing the type-2 diabetes patients with new treatment options. Furthermore, the market companies are focused on increasing the capacity of production including facility launch to widen their services and offerings, which is expected to register robust growth in the global injectable drug delivery market. For instance, Gerresheimer AG, in March 2019, announced plans to construct a new facility in North Macedonia, Europe for the production of prefillable syringes and pharmaceutical plastic systems for the medical technology sector and pharmaceutical industry. Moreover, rising awareness of concern and safety regarding needlestick injuries is a crucial aspect driving the global injectable drug delivery market. As per the 2012 report from Health Protection Agency (HPA), from 2002 to 2011 injuries among dental and medical professionals while patients treatment upsurged by 131% (100-231)

“Limited Time Offer”

Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/2768

Major market players are adopting strategies including acquisitions and collaborations to improve the service offerings. For instance, SMC Ltd., in December 2016, completed the acquisition of Oval Medical Technologies Ltd. in order to enlarge its capabilities of product offerings and drug delivery to pharmaceutical producers. Similarly, Numedico Technologies, in December 2017, collaborated with Mana Medical Services. As per the agreement, Mana Medical Services will dispense ClickZip Needle Retractable Safety Syringe in Australia and New Zealand.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/injectable-drug-delivery-market-to-surpass-us-325-billion-by-2026-1457

Global Injectable Drug Delivery Market: Key Takeaways

● The global injectable drug delivery market is projected to witness a CAGR of 8.3% over the forecast period, due to market players launching products. For instance, AbbVie GK and Eisai Co., Ltd., in 2018, introduced an auto-injection delivery system for HUMIRA for Subcutaneous Injection 80 mg Pen 0.8 mL and 40 mg Pen 0.4 mL.

● In 2018, the plastic segment, On the basis of material type, held the highest share in the global injectable drug delivery market, due to the launch of cartridges and plastic syringes For instance, Gerresheimer, in June 2016, introduced a prefillable plastic syringe having integrated cannula - Gx RTF ClearJect, manufactured from high-performance cyclo olefin polymer (COP) plastic for high-viscosity agents and sensitive medications.

● On the basis of usability, in 2018, the disposable segment held the highest share in the global injectable drug delivery market, due to notable rise in self-administration for treating chronic diseases.

● In 2018, the subcutaneous segment, on the basis of route of administration, gained a dominant share in the global injectable drug delivery market, since auto-injectors and pens are used majorly for biopharmaceuticals subcutaneous delivery, majorly to self-administer.

● In 2018, home care settings segment, on the basis of end-user type, gained the highest share in the global injectable drug delivery market, due to home-based reliable and cost-effective care to treat chronic conditions.

● Major players functioning in global injectable drug delivery market consists, Becton, Pfizer Inc., Dickinson and Company, Novo Nordisk A/S, Carl-Zeiss-Stiftung, Gerresheimer AG, Vetter Pharma-Fertigung GmbH & Co. KG, Terumo Corporation, SHL Group, Injex Pharma GmbH and Owen Mumford Limited.

To understand Research Methodology, please click https://www.coherentmarketinsights.com/market-insight/injectable-drug-delivery-market-2768

Table of Content

Global Injectable Drug Delivery Market Research Report
Section 1: Global Injectable Drug Delivery Industry Overview
Section 2: Global Economic Impact on Injectable Drug Delivery Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Injectable Drug Delivery Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Injectable Drug Delivery Market Forecast

Other Related Reports:

Global Oxytocic Pharmaceuticals Market Insights - https://www.medgadget.com/2021/08/oxytocic-pharmaceuticals-market-10-2-cagr-find-out-growth-potential-through-demand-forecast-2027-cmi.html

North America and Europe Artificial Pancreas Systems Market Insights - https://www.medgadget.com/2021/08/north-america-europe-artificial-pancreas-systems-market-2021-snapshot-industry-predict-a-long-term-growth-at-12-9-cagr-by-revenue-us-320-2-million-by-2027-coherent-market-insights.html

Europe Platelet-rich Plasma Market Insights - https://www.medgadget.com/2021/08/europe-platelet-rich-plasma-market-value-to-worth-over-us-75-8-million-at-7-1-cagr-growth-rate-technology-snapshot-with-solution-to-drive-market-growth-by-2027.html

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

This release was published on openPR.